$CLS

MIONIS ROBERT sold $18.8M of CLS (indirect holdings)

MIONIS ROBERT (Chief Executive Officer) sold 51,061 indirectly-held shares of CELESTICA INC (CLS) at an average of $368.41 ($361.89–$378.50, $18.81M total) across 18 trades on 2026-08-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MIONIS ROBERT
Published Aug 7, 2026, 12:20 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLS
Neutral
medium confidence
Mentioned
$CLS
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLSNeutralLow
01

Why it matters

The disclosure provides a concrete datapoint on insider selling size and timing, but it does not include new operational, financial, or regulatory information about Celestica.

02

Market read

For CLS traders, the actionable takeaway is insider selling of about $18.8M on 2026-08-05, which may slightly pressure sentiment but is unlikely to drive fundamentals by itself.

03

What to watch

Traders may over-weight insider sales; the key incremental signal would be whether there are concurrent operational or guidance changes, which are not present here.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-06 for 2026-08-05 sale; relevant for today’s sentiment/positioning

Background

The article is an SEC Form 4 insider transaction disclosure for Celestica (CLS), reported by CEO Mionis Robert as an indirect holding sale under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$CLSNeutralMedium confidence
Context

Celestica CEO Mionis Robert sold $18.81M of CLS shares via a 10b5-1 plan, with 51,061 shares sold across 18 trades on 2026-08-05.

Expected impact

Likely limited, short-lived impact unless paired with other company-specific news.

Evidence & confidence

The filing is a Form 4 open-market sale under a pre-arranged 10b5-1 plan; such sales are often routine and typically carry less signaling value than discretionary sales.

Market effects

Minimal, as this is company-specific insider activity without sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity planning rather than bearish expectations.

Key entities

  • CELESTICA INC

    Subject of the Form 4 insider transaction disclosure (CLS).

  • MIONIS ROBERT

    CEO and officer/director reporting an open-market sale of shares via a 10b5-1 plan.

Related articles

$CLSMedAI 8/10

Celestica Completes Equity Offering

Celestica Inc. (NYSE: CLS, TSX: CLS) said it completed its equity offering of 9,677,419 common shares at $310 per share. Including the underwriters’ option, 11,129,031 shares were sold for about $3.45 billion in gross proceeds. Net proceeds will be used for working capital, capital expenditures, and general corporate purposes.

$CLSHighAI 9/10

Celestica Falls After Pricing $3 Bln Equity Offering

Celestica Inc. (CLS) shares fell nearly 12% after the company priced a $3.0 billion public equity offering. According to the company, it sold 9.68 million common shares at $310 each, raising expected gross proceeds of $3.0 billion, and gave underwriters a 30-day option for up to 1.45 million additional shares. CLS traded around $319.48, down about $43.28.

$CLSHighAI 9/10

Why is Celestica stock sliding today?

Celestica (CLS) shares fell 13.7% after the company priced a $3 billion common stock offering at $310 per share, down from the prior close of $362.76. Celestica plans to sell about 9.68 million treasury shares, with underwriters able to buy 1.45 million more. Management said the raise supports AI compute and networking demand.

$CLSMedAI 8/10

Celestica Announces Pricing of Equity Offering

Celestica Inc. (NYSE: CLS, TSX: CLS) priced an equity offering of 9,677,419 common shares at $310 per share. Gross proceeds are expected at about $3.0 billion before underwriting discounts and expenses. Underwriters have a 30-day option to buy up to 1,451,612 additional shares. Net proceeds will fund working capital and capital expenditures, among other purposes. Closing is expected around Aug. 7, 2026.